Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Cerebral venous sinus thrombus" refers to a blood clot forming within the major venous sinuses or large draining veins of the brain. This obstruction impedes normal venous blood outflow, which can lead to increased intracranial pressure, local venous infarction, hemorrhagic transformation, and compromised cerebrospinal fluid absorption. Clinically, this can manifest as headache, focal neurological signs, seizures, and in severe cases, coma or death. Management targets the underlying thrombus with anticoagulation and, in select cases, thrombolysis or surgical intervention
Anticoagulants: prevent propagation or formation of additional thrombi by inhibiting the clotting cascade Thrombolytics: degrade existing fibrin in thrombi to dissolve the clot
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cerebral venous sinus thrombus (CVST).